Merck @MerckToday we shared positive Phase 2b results evaluating our investigational anti-TL1A biologic in adults with moderate to severe hidradenitis suppurativa (HS). Learn more: go.merck.com/~73c0:09 1080pSep 30, 2026, 12:22 PM UTC 14 18